SlideShare a Scribd company logo
PRENATAL DIAGNOSTIC
TECHNIQUES
FIRST TRIMESTER SCREENING
 11- 13+6 weeks
 CRL of 45- 84mm.
Maternal age
Nuchal translucency
Maternal serum beta hCG
Maternal serum PAPP-A level
Additional ultrasound markers
 Maternal age
Trisomy 13,18 ,21- ↑ses with maternal age
detection rate ↑ to 75-80%(maternal age+ NT)
 Nuchal translucency
maximum thickness of subcutaneous translucent area
between skin and soft tissue overlying fetal spine at the back
of neck.
CRL 38- 84mm
NUCHALTRANSLUCENCY
 Mid sagittal view
 Head in neutral position in
line with spine
 Fetal neck skin
differentiated from amnion
by fetal movt
 Widest part should be
measured
 Callipers should be placed
in inner border of white line
BIOCHEMICAL MARKERS IN FIRST TRIMESTER
 beta hCG and PAPP-A
Beta hCG MoM
normal 1
Trisomy 21 2
Trisomy 18 0.2
Trisomy 13 0.5
PAPP-A MoM
Normal 1
Trisomy 21 0.5
Trisomy 18 0.2
Trisomy 13 0.3
Beta hCG is lower in women who are HIV positive
ADDITIONAL FIRST TRIMESTER ULTRASOUND MARKERS
1. Nasal bone
2. Reversed a wave in ductus venosus
3. Tricuspid regurgitation
4. Wide fronto maxillary fascial angle
COMBINED FIRST TRIMESTER SCREENING
 NT+ β Hcg +PAPP-A
 79-87%
 Maternal age affects first trimestic aneuploidy scan
 <35years :- 67-75%
 >35years :- 90-95%
SECOND TRIMESTER SCREENING
 Between15 and 21 weeks of gestation
Detailed ultrasound scan
Maternal serum beta hCG
Maternal serum AFP
Maternal serum uE3 level
Maternal serum inhibin A level
 Beta hCG- peaks at 15 wks→ gradually falls at17-22wks
Trisomy 21- increased in both trimesters
 Alpha fetoprotein- produced by liver and gastrointestinal
tract of fetus
- marker of open spina bifida
- Trisomy 21 ↓ by 25%
 Free Estriol- Trisomy 21 ↓ by 25%
 Inhibin A- ↑ to 1.77 MoM in trisomy 21
COMBINED FIRST AND SECOND TRIMESTER
SCREENING
 Integrated screening
NT+ serum analytes at 11 to 14 weeks+ quadruple
markers at 15 to 20 weeks
Highest Down syndrome detection rate( 94-96%)
 Sequential screening
stepwise sequential screening
contingent sequential screening
CELL FREE FETAL DNA SCREENING
 Non invasive prenatal screening
 Not recommended for multiple gestation
 High specificity and sensitivity for trisomy 18 and 21
 Doesnot assess risk of fetal anomalies such as neural tube defects
or ventral wall defects
 Recommended for women >35 yrs
usg findings of increased risk of aneuploidy
H/O trisomy affected offspring
positive first or second trimester screening result
parent wth balanced robertsonian translocation
ACOG 2015
GENETIC COUNSELING
 3% of newborns have major congenital anomalies.
 Etiologic factors:
1. Chromosomal abnormalities
2. Single gene disorders
3. Polygenic or multifactorial disorders
4. Teratogenic disorders due to exposure of
exogenous factors
MATERNAL RISK FACTORS
 Maternal age > 35 years
 Family history of neural tube defects
 Previous baby born with neural tube defect
 Previous child with chromosomal anomaly
 One or both parents – carriers of sex linked or
autosomal traits
 One parent is known to carry a balanced
translocation
 History of recurrent miscarriage
PRENATAL RISK FACTORS
 Oligohydramnios
 Polyhydramnios
 Severe symmetrical IUGR
 Abnormal USG findings
 Uncontrolled diabetes mellitus in the
periconceptional period
 Contact with infection
 Presence of soft tissue markers
 Abnormal maternal serum screening
INVASIVE PROCEDURE FOR PRENATAL
DIAGNOSIS
 Chorionic villus sampling
 Amniocentesis
 Cordocentesis or percutaneous umbilical blood
sampling
CHORIONIC VILLUS SAMPLING
 Diagnosed by italian biologist Giuseppe simoni,
1983
 Diagnosis of genetic disorders
3 approaches:
 Transcervically-10wks to 13 wks
 Transabdominally-10wks to term
 Transvaginal(rare)
PROCEDURE OF TRANSCERVICAL
ADVANTAGES OF TRANSCERVICAL
CVS
 Genetic diagnosis is achieved at an early
gestational age.
 Comfortable to the patient
 Technically simple.
DISADVANTAGES
 High risk of fetal loss than traditional amniocentesis
 Chromosome composition & enzyme composition
of the chorionic villus is ocassionally different from
the fetal cells
 Difficult if the placenta is above the lower one third
of the uterus
CONTRAINDICATIONS
-Positive neisseria gonorrhoea culture of the cervix
-Active genital herpes
-Active bleeding
-Maternal coagulopathy
-Cervical stenosis
-Severe cervicitis
-Uterine myomas
-IUD inside the pregnant uterus.
TRANSABDOMINAL CVS
 It certainally reduces the potential risk of infection
when compared to vaginal procedure.
 Two techniques
-Single needle
-Two needle
PROCEDURE
ADVANTAGES OF TRANSABDOMINAL
CVS
 Minimal risk of infection
 It does not cause vaginal bleeding
 Performed in the second and third trimester.
DISADVANTAGES
 Amount of tissue obtained is less than that with
transcervical cvs.
 Patient discomfort is more.
 Difficult to perform if placenta is posterior.
TRANSVAGINAL CVS
INDICATIONS:
-Uterine retroversion
-Myomas
-Placental localization
 Chorionic villus is obtained by transvaginal
aspiration under guidance with an endovaginal
probe.
LABORATORY ASPECTS OF CVS
 Direct cytogenetic analysis
 Long term tissue culture
COMPLICATIONS
 Fetal loss(1-2%)
 Oromandibular limb deformities
 Vaginal bleeding
 Limb reduction deformity
False positive results (2-3%) - placental mosaics
and maternal cell contamination
AMNIOCENTESIS
DEF:
Deliberate puncture of the amniotic fluid sac per
abdomen
 Carried out as an op procedure.
 Early:11-14 , Late: 14-16
 Proper counselling.
 USG examination.
 Main risk factors:
-Rh isoimmunization in Rh negative mothers.
-Infection
 Other risks:
-Changes with the gestational age
-Preprocedure or concominant use of the USG.
-Size of the needle
-Number of needle insertions
-Characteristics of the amniotic fluid
-Experience & ability of the indivudual performance.
ADVANTAGES
 Degree of accuracy
 Degree of hemolytic process in the fetus
 Disadvantages:
-Pregnancy loss
-Amniotic fluid leekage
-Fetal trauma
PRECAUTIONS
 Prior sonographic localisation of placenta is
desirable to prevent bloody tap and fetomaternal
bleeding
 Prophylatic administration of 100mg of anti-D
immunoglobulin in Rh-negative nonimmunized
mother.
CORDOCENTESIS
 Described in 1983 by Fernand Daffos.
 Procedure to obtain fetal blood.
INDICATIONS:
-Fetal transmission of toxoplasmosis
-Rapid karyotype of the fetus with anatomic
deformities
-Chromosomal abnormalities
CORDOCENTESIS
USES:
 Fetal abnormalities detected by USG.
 Fetal growth retardation
 Polyhydramnios
 Hereditary defeciences of other haemostatic
system
 Hemoglobinopathies
 Metabolic disorders.
ADVANTAGES
 High quality karyotype in 48-72 hrs rather than 10-
14 days that is needed for amniotic tissue culture.
 Vein is larger in size.
COMPLICATIONS
 Bleeding from the puncture site(30%)
 Fetal bradycardia(5%)
CVS
AMNIOCENETESI
S
CORDOCENTESIS
TIME Transcervical 10-
13wks,
Transadominal 10
weeks to term
After 15
weeks(early 12-14
weeks)
18-20 weeks
MATERIALS FOR
STUDY
Trophoblast cells Fetal fibroblasts
Fluid for
biochemical study
Fetal white blood
cells(others-infection
and biochemical study)
KARYOTYPE
RESULT
Direct preparation:
24-48 hrs
Culture: 10-14
days
Culture:3-4weeks 24-48hrs
FETAL LOSS 0.5-1% 0.5% 1-2%
ACCURACY Accurate Highly accurate Highly accurate
TERMINATION OF
PREGNANCY
1st trimester-safe 2nd trimester-risky 2nd trimester-risky
HISTORY
 Introduced initially in 1990, at
Hammersmith Hospital,
London
 By Handyside .
 Combines advances in
molecular genetics & ART
PGD INDICATIONS
Procedure is offered to couples:
 With known genetic disorders
- autosomal recessive
- autosomal dominant
- x linked disorders
- triplet repeat disorders
 requesting sex selection for X-
linked disorders
 Chromosomal abnormalities
PGD INDICATIONS
The procedure has also been offered to couples:
undergoing IVF at risk for aneuploidy
maternal age > 35 years
Prior trisomic conception
with recurrent pregnancy losses
Prior failed IVF cycles (>3 prior embryo transfers
with high quality, morphologically normal embryos)
Requesting PGD for HLA-typing (to allow selection
of embryos that are histocompatible with live
siblings)
Requesting sex selection for “family balancing”
Cancer predisposition syndromes.
PRECONCEPTIONAL PRENATAL DIAGNOSTIC
TECHNIQUES ACT(PC PNDT)
 Why this act ?
. Prohibition of sex selection
. Detection of genetic abnormalities/
metabolic disorders/ chromosomal
abnormalities/ congenital malformations/ sex
linked disorders
. Prevention of sex determination leading to
female feticide
 Genetic counseling centre- a gynecologist or a
pediatrician having 6 months experience/ 4wks
experience in genetic counseling/ a medical
geneticists
 Genetic laboratory- a medical geneticist/ a lab
technician having 1 yr experience in conducting
prenatal diagnostic procedures
 Genetic clinic/ ultrasound clinic
gynecologist having experience of performing at
least 20 procedures
a sonologist/ imaging specialist/ registered
medical practitioner/ medical geneticists
GENETIC TESTS
 Cytogenetic analysis
 Fluorescence in situ hybridization
 Southern blotting
 Polymerase chain reaction
 Linkage analysis
 Chromosomal micro array analysis
CYTOGENETIC ANALYSIS
FLUOROSCENCE IN SITU HYBRIDISATION
SOUTHERN BLOTTING
TYPES OF CHROMOSOMAL ABNORMALITIES
 Numerical
- trisomy
- monosomy
 Structural- deletions/duplications/ translocations
Chromosomal
abnormality
Genetic syndrome Incidence per
10000 births
Trisomy 21 Down 15
Trisomy 18 Edward 3
Trisomy 13 Patau 2
Monosomy X Turner 2(female)
XXY Klinefelter 10(male)
 Translocation- reciprocal
robertsonian
 inversions – pericentric
paracentric
.
Prenatal diagnosis

More Related Content

What's hot

Genetic counselling & Prenatal Diagnosis
Genetic counselling & Prenatal Diagnosis Genetic counselling & Prenatal Diagnosis
Genetic counselling & Prenatal Diagnosis
DrDilip86
 
From down syndrome screening to nipt
From down syndrome screening to niptFrom down syndrome screening to nipt
From down syndrome screening to nipt
PathKind Labs
 
Preimplantation genetic diagnosis (pgd) PGD
Preimplantation genetic diagnosis (pgd) PGDPreimplantation genetic diagnosis (pgd) PGD
Preimplantation genetic diagnosis (pgd) PGD
dr. gokul reshmi mariappan
 
Fetal DNA in maternal serum
Fetal DNA in maternal serumFetal DNA in maternal serum
Fetal DNA in maternal serum
Dr. Kapil Dev Doddamani
 
Micro array analysis
Micro array analysisMicro array analysis
Micro array analysis
NARENDRA MALHOTRA
 
Maternal serum screening
Maternal serum screeningMaternal serum screening
Maternal serum screening
Dr.M.Prasad Naidu
 
Screening
ScreeningScreening
Screening
Pinky Premmy
 
Pre implantation genetic diagnosis (pgd)
Pre implantation genetic diagnosis (pgd)Pre implantation genetic diagnosis (pgd)
Pre implantation genetic diagnosis (pgd)BALASUBRAMANIAM IYER
 
PRENATAL DIAGONOSIS OF GENETIC DISORDERS
PRENATAL DIAGONOSIS OF GENETIC DISORDERSPRENATAL DIAGONOSIS OF GENETIC DISORDERS
PRENATAL DIAGONOSIS OF GENETIC DISORDERS
Dikshat Pruthi
 
Prenatal diagnosis test
Prenatal diagnosis testPrenatal diagnosis test
Prenatal diagnosis test
qussai abbas
 
Maternal screening in Pregnancy (Double & quadruple marker)
Maternal screening in Pregnancy (Double & quadruple marker)Maternal screening in Pregnancy (Double & quadruple marker)
Maternal screening in Pregnancy (Double & quadruple marker)
Dr Nupur Gupta High Risk Obstetrician
 
NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre
Lifecare Centre
 
prenatal diagnosis
prenatal diagnosis prenatal diagnosis
prenatal diagnosis ployswift
 
Genetic counseling in modern dr. sharda jain
Genetic counseling in modern dr. sharda jainGenetic counseling in modern dr. sharda jain
Genetic counseling in modern dr. sharda jainLifecare Centre
 
Amniocentesis
AmniocentesisAmniocentesis
Amniocentesis
TaqadasSajjad
 
Amniocentesis ,CVS and karyotyping
Amniocentesis ,CVS and karyotypingAmniocentesis ,CVS and karyotyping
Amniocentesis ,CVS and karyotyping
DrPoojaPandey4
 
Foetal congenital anomalies in pregnancy
Foetal congenital anomalies in pregnancyFoetal congenital anomalies in pregnancy
Foetal congenital anomalies in pregnancy
Aloy Okechukwu Ugwu
 
Presentation on Preimplantation Genetic Diagnosis (PGD)
Presentation on Preimplantation Genetic Diagnosis (PGD)Presentation on Preimplantation Genetic Diagnosis (PGD)
Presentation on Preimplantation Genetic Diagnosis (PGD)
Dr.Laxmi Agrawal Shrikhande
 
Fetal therapy
Fetal therapyFetal therapy
Fetal therapy
drankitguptamd
 
Aneuploidy screening Aneuploidy screening
Aneuploidy screening  Aneuploidy screening Aneuploidy screening  Aneuploidy screening
Aneuploidy screening Aneuploidy screening
Dr Praman Kushwah
 

What's hot (20)

Genetic counselling & Prenatal Diagnosis
Genetic counselling & Prenatal Diagnosis Genetic counselling & Prenatal Diagnosis
Genetic counselling & Prenatal Diagnosis
 
From down syndrome screening to nipt
From down syndrome screening to niptFrom down syndrome screening to nipt
From down syndrome screening to nipt
 
Preimplantation genetic diagnosis (pgd) PGD
Preimplantation genetic diagnosis (pgd) PGDPreimplantation genetic diagnosis (pgd) PGD
Preimplantation genetic diagnosis (pgd) PGD
 
Fetal DNA in maternal serum
Fetal DNA in maternal serumFetal DNA in maternal serum
Fetal DNA in maternal serum
 
Micro array analysis
Micro array analysisMicro array analysis
Micro array analysis
 
Maternal serum screening
Maternal serum screeningMaternal serum screening
Maternal serum screening
 
Screening
ScreeningScreening
Screening
 
Pre implantation genetic diagnosis (pgd)
Pre implantation genetic diagnosis (pgd)Pre implantation genetic diagnosis (pgd)
Pre implantation genetic diagnosis (pgd)
 
PRENATAL DIAGONOSIS OF GENETIC DISORDERS
PRENATAL DIAGONOSIS OF GENETIC DISORDERSPRENATAL DIAGONOSIS OF GENETIC DISORDERS
PRENATAL DIAGONOSIS OF GENETIC DISORDERS
 
Prenatal diagnosis test
Prenatal diagnosis testPrenatal diagnosis test
Prenatal diagnosis test
 
Maternal screening in Pregnancy (Double & quadruple marker)
Maternal screening in Pregnancy (Double & quadruple marker)Maternal screening in Pregnancy (Double & quadruple marker)
Maternal screening in Pregnancy (Double & quadruple marker)
 
NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre
 
prenatal diagnosis
prenatal diagnosis prenatal diagnosis
prenatal diagnosis
 
Genetic counseling in modern dr. sharda jain
Genetic counseling in modern dr. sharda jainGenetic counseling in modern dr. sharda jain
Genetic counseling in modern dr. sharda jain
 
Amniocentesis
AmniocentesisAmniocentesis
Amniocentesis
 
Amniocentesis ,CVS and karyotyping
Amniocentesis ,CVS and karyotypingAmniocentesis ,CVS and karyotyping
Amniocentesis ,CVS and karyotyping
 
Foetal congenital anomalies in pregnancy
Foetal congenital anomalies in pregnancyFoetal congenital anomalies in pregnancy
Foetal congenital anomalies in pregnancy
 
Presentation on Preimplantation Genetic Diagnosis (PGD)
Presentation on Preimplantation Genetic Diagnosis (PGD)Presentation on Preimplantation Genetic Diagnosis (PGD)
Presentation on Preimplantation Genetic Diagnosis (PGD)
 
Fetal therapy
Fetal therapyFetal therapy
Fetal therapy
 
Aneuploidy screening Aneuploidy screening
Aneuploidy screening  Aneuploidy screening Aneuploidy screening  Aneuploidy screening
Aneuploidy screening Aneuploidy screening
 

Similar to Prenatal diagnosis

prenatal genet.pptx
prenatal genet.pptxprenatal genet.pptx
prenatal genet.pptx
krts131j
 
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandunganPrenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Hendrik Sutopo
 
genetic & genomic in prenatal diagnosis.pptx
genetic & genomic in prenatal diagnosis.pptxgenetic & genomic in prenatal diagnosis.pptx
genetic & genomic in prenatal diagnosis.pptx
Evita637753
 
Lecture 11 Prenatal diagnosis
Lecture 11 Prenatal diagnosisLecture 11 Prenatal diagnosis
Lecture 11 Prenatal diagnosis
Public Health & Medical Academy
 
Prenatal diagnosis of down syndrome
Prenatal diagnosis of down syndromePrenatal diagnosis of down syndrome
Prenatal diagnosis of down syndrome
FatmaGhoneim3
 
screening for down syndrome
screening for down syndromescreening for down syndrome
screening for down syndrome
Sadaf Khan
 
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
Lifecare Centre
 
Ultrasonography Scans in Pregnancy
Ultrasonography Scans in PregnancyUltrasonography Scans in Pregnancy
Ultrasonography Scans in Pregnancy
DrNisheethOza
 
prenatal diagnosis.ppt..pptx
prenatal diagnosis.ppt..pptxprenatal diagnosis.ppt..pptx
prenatal diagnosis.ppt..pptx
MMridhunaManoharan
 
Gyula Richard Nagy: Prenatal diagnostic methods
Gyula Richard Nagy: Prenatal diagnostic methodsGyula Richard Nagy: Prenatal diagnostic methods
Gyula Richard Nagy: Prenatal diagnostic methods
Katalin Cseh
 
Genetic counselling 7 march13-Dr.Gourav
Genetic counselling 7 march13-Dr.GouravGenetic counselling 7 march13-Dr.Gourav
Genetic counselling 7 march13-Dr.GouravGourav Thakre
 
Practical 5 07
Practical 5 07Practical 5 07
Practical 5 07medik.cz
 
Screening for fetal abnormality in first and second.pptx
Screening for fetal abnormality in first and second.pptxScreening for fetal abnormality in first and second.pptx
Screening for fetal abnormality in first and second.pptx
poonamkirtipal
 
Genetictesting 140305094745-phpapp01
Genetictesting 140305094745-phpapp01Genetictesting 140305094745-phpapp01
Genetictesting 140305094745-phpapp01t7260678
 
pregnancy &prenatal diagnosisi
pregnancy &prenatal diagnosisipregnancy &prenatal diagnosisi
pregnancy &prenatal diagnosisi
PALANIANANTH.S
 
Fetal assessment and prenatal diagnosis
Fetal assessment and prenatal diagnosisFetal assessment and prenatal diagnosis
Fetal assessment and prenatal diagnosis
Drhunny88
 
Prenatal and preimplantation diagnosis 22.04.2021
Prenatal and preimplantation diagnosis 22.04.2021Prenatal and preimplantation diagnosis 22.04.2021
Prenatal and preimplantation diagnosis 22.04.2021
Shazia Iqbal
 
Antenatal monitoring of fetal well being 2
Antenatal monitoring of fetal well being 2Antenatal monitoring of fetal well being 2
Antenatal monitoring of fetal well being 2
ravikanth gowder
 
Prenatal cytogenetic
Prenatal cytogenetic Prenatal cytogenetic
Prenatal cytogenetic
Mahmoud Mohammadi
 
First trimester screening Down's
First trimester screening Down's First trimester screening Down's
First trimester screening Down's
ajay dhawle
 

Similar to Prenatal diagnosis (20)

prenatal genet.pptx
prenatal genet.pptxprenatal genet.pptx
prenatal genet.pptx
 
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandunganPrenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
Prenatal Testing, deteksi kelainan bawaan sejak dalam kandungan
 
genetic & genomic in prenatal diagnosis.pptx
genetic & genomic in prenatal diagnosis.pptxgenetic & genomic in prenatal diagnosis.pptx
genetic & genomic in prenatal diagnosis.pptx
 
Lecture 11 Prenatal diagnosis
Lecture 11 Prenatal diagnosisLecture 11 Prenatal diagnosis
Lecture 11 Prenatal diagnosis
 
Prenatal diagnosis of down syndrome
Prenatal diagnosis of down syndromePrenatal diagnosis of down syndrome
Prenatal diagnosis of down syndrome
 
screening for down syndrome
screening for down syndromescreening for down syndrome
screening for down syndrome
 
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
“Integrated Approach: Utilizing Biomarkers, Non-Invasive Prenatal Screening (...
 
Ultrasonography Scans in Pregnancy
Ultrasonography Scans in PregnancyUltrasonography Scans in Pregnancy
Ultrasonography Scans in Pregnancy
 
prenatal diagnosis.ppt..pptx
prenatal diagnosis.ppt..pptxprenatal diagnosis.ppt..pptx
prenatal diagnosis.ppt..pptx
 
Gyula Richard Nagy: Prenatal diagnostic methods
Gyula Richard Nagy: Prenatal diagnostic methodsGyula Richard Nagy: Prenatal diagnostic methods
Gyula Richard Nagy: Prenatal diagnostic methods
 
Genetic counselling 7 march13-Dr.Gourav
Genetic counselling 7 march13-Dr.GouravGenetic counselling 7 march13-Dr.Gourav
Genetic counselling 7 march13-Dr.Gourav
 
Practical 5 07
Practical 5 07Practical 5 07
Practical 5 07
 
Screening for fetal abnormality in first and second.pptx
Screening for fetal abnormality in first and second.pptxScreening for fetal abnormality in first and second.pptx
Screening for fetal abnormality in first and second.pptx
 
Genetictesting 140305094745-phpapp01
Genetictesting 140305094745-phpapp01Genetictesting 140305094745-phpapp01
Genetictesting 140305094745-phpapp01
 
pregnancy &prenatal diagnosisi
pregnancy &prenatal diagnosisipregnancy &prenatal diagnosisi
pregnancy &prenatal diagnosisi
 
Fetal assessment and prenatal diagnosis
Fetal assessment and prenatal diagnosisFetal assessment and prenatal diagnosis
Fetal assessment and prenatal diagnosis
 
Prenatal and preimplantation diagnosis 22.04.2021
Prenatal and preimplantation diagnosis 22.04.2021Prenatal and preimplantation diagnosis 22.04.2021
Prenatal and preimplantation diagnosis 22.04.2021
 
Antenatal monitoring of fetal well being 2
Antenatal monitoring of fetal well being 2Antenatal monitoring of fetal well being 2
Antenatal monitoring of fetal well being 2
 
Prenatal cytogenetic
Prenatal cytogenetic Prenatal cytogenetic
Prenatal cytogenetic
 
First trimester screening Down's
First trimester screening Down's First trimester screening Down's
First trimester screening Down's
 

More from obgymgmcri

Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
obgymgmcri
 
Premalignant lesion of vulva
Premalignant lesion of vulvaPremalignant lesion of vulva
Premalignant lesion of vulva
obgymgmcri
 
Preterm labour dr seeteshviii&amp;ix_
Preterm labour dr seeteshviii&amp;ix_Preterm labour dr seeteshviii&amp;ix_
Preterm labour dr seeteshviii&amp;ix_
obgymgmcri
 
Endoscopy in gynaecology
Endoscopy in gynaecologyEndoscopy in gynaecology
Endoscopy in gynaecology
obgymgmcri
 
Obstructed labour
Obstructed labourObstructed labour
Obstructed labour
obgymgmcri
 
Breech presentation
 Breech presentation Breech presentation
Breech presentation
obgymgmcri
 
Endomtriosis seetesh mgmcri
Endomtriosis  seetesh mgmcriEndomtriosis  seetesh mgmcri
Endomtriosis seetesh mgmcri
obgymgmcri
 
Complications of third stage of labour
Complications of third stage of labourComplications of third stage of labour
Complications of third stage of labour
obgymgmcri
 
Fibroid uterus
Fibroid uterusFibroid uterus
Fibroid uterus
obgymgmcri
 
Prolapse - 1
Prolapse - 1Prolapse - 1
Prolapse - 1
obgymgmcri
 
Antepartum haemorrhage i
Antepartum haemorrhage iAntepartum haemorrhage i
Antepartum haemorrhage i
obgymgmcri
 
Abnormalities of-placenta-and-cordppt
Abnormalities of-placenta-and-cordpptAbnormalities of-placenta-and-cordppt
Abnormalities of-placenta-and-cordppt
obgymgmcri
 
Genital tract fistula
Genital tract fistulaGenital tract fistula
Genital tract fistula
obgymgmcri
 
Anemia in Pregnancy
Anemia in PregnancyAnemia in Pregnancy
Anemia in Pregnancy
obgymgmcri
 
Diabetes in pregnancy 2
Diabetes in pregnancy 2Diabetes in pregnancy 2
Diabetes in pregnancy 2
obgymgmcri
 
Female infertility - 1
Female infertility - 1Female infertility - 1
Female infertility - 1
obgymgmcri
 
Female infertility (2)
Female infertility (2)Female infertility (2)
Female infertility (2)
obgymgmcri
 
Vbac
VbacVbac
Physiological changes in pregnancy (part 1)
Physiological changes in pregnancy (part 1)Physiological changes in pregnancy (part 1)
Physiological changes in pregnancy (part 1)
obgymgmcri
 

More from obgymgmcri (20)

Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
 
Premalignant lesion of vulva
Premalignant lesion of vulvaPremalignant lesion of vulva
Premalignant lesion of vulva
 
Preterm labour dr seeteshviii&amp;ix_
Preterm labour dr seeteshviii&amp;ix_Preterm labour dr seeteshviii&amp;ix_
Preterm labour dr seeteshviii&amp;ix_
 
Endoscopy in gynaecology
Endoscopy in gynaecologyEndoscopy in gynaecology
Endoscopy in gynaecology
 
Obstructed labour
Obstructed labourObstructed labour
Obstructed labour
 
Breech presentation
 Breech presentation Breech presentation
Breech presentation
 
Endomtriosis seetesh mgmcri
Endomtriosis  seetesh mgmcriEndomtriosis  seetesh mgmcri
Endomtriosis seetesh mgmcri
 
Complications of third stage of labour
Complications of third stage of labourComplications of third stage of labour
Complications of third stage of labour
 
Fibroid uterus
Fibroid uterusFibroid uterus
Fibroid uterus
 
Prolapse - 1
Prolapse - 1Prolapse - 1
Prolapse - 1
 
Antepartum haemorrhage i
Antepartum haemorrhage iAntepartum haemorrhage i
Antepartum haemorrhage i
 
Abnormalities of-placenta-and-cordppt
Abnormalities of-placenta-and-cordpptAbnormalities of-placenta-and-cordppt
Abnormalities of-placenta-and-cordppt
 
Genital tract fistula
Genital tract fistulaGenital tract fistula
Genital tract fistula
 
Anemia in Pregnancy
Anemia in PregnancyAnemia in Pregnancy
Anemia in Pregnancy
 
HRT
HRTHRT
HRT
 
Diabetes in pregnancy 2
Diabetes in pregnancy 2Diabetes in pregnancy 2
Diabetes in pregnancy 2
 
Female infertility - 1
Female infertility - 1Female infertility - 1
Female infertility - 1
 
Female infertility (2)
Female infertility (2)Female infertility (2)
Female infertility (2)
 
Vbac
VbacVbac
Vbac
 
Physiological changes in pregnancy (part 1)
Physiological changes in pregnancy (part 1)Physiological changes in pregnancy (part 1)
Physiological changes in pregnancy (part 1)
 

Recently uploaded

Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
Secret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage LondonSecret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage London
Secret Tantric - VIP Erotic Massage London
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
KRISTELLEGAMBOA2
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
roti bank
 
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfNavigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Enterprise Wired
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
rajkumar669520
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
priyabhojwani1200
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
Mangaiarkkarasi
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 

Recently uploaded (20)

Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
Secret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage LondonSecret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage London
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
 
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfNavigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 

Prenatal diagnosis

  • 2. FIRST TRIMESTER SCREENING  11- 13+6 weeks  CRL of 45- 84mm. Maternal age Nuchal translucency Maternal serum beta hCG Maternal serum PAPP-A level Additional ultrasound markers
  • 3.  Maternal age Trisomy 13,18 ,21- ↑ses with maternal age detection rate ↑ to 75-80%(maternal age+ NT)  Nuchal translucency maximum thickness of subcutaneous translucent area between skin and soft tissue overlying fetal spine at the back of neck. CRL 38- 84mm
  • 4. NUCHALTRANSLUCENCY  Mid sagittal view  Head in neutral position in line with spine  Fetal neck skin differentiated from amnion by fetal movt  Widest part should be measured  Callipers should be placed in inner border of white line
  • 5. BIOCHEMICAL MARKERS IN FIRST TRIMESTER  beta hCG and PAPP-A Beta hCG MoM normal 1 Trisomy 21 2 Trisomy 18 0.2 Trisomy 13 0.5 PAPP-A MoM Normal 1 Trisomy 21 0.5 Trisomy 18 0.2 Trisomy 13 0.3 Beta hCG is lower in women who are HIV positive
  • 6. ADDITIONAL FIRST TRIMESTER ULTRASOUND MARKERS 1. Nasal bone 2. Reversed a wave in ductus venosus 3. Tricuspid regurgitation 4. Wide fronto maxillary fascial angle
  • 7.
  • 8. COMBINED FIRST TRIMESTER SCREENING  NT+ β Hcg +PAPP-A  79-87%  Maternal age affects first trimestic aneuploidy scan  <35years :- 67-75%  >35years :- 90-95%
  • 9. SECOND TRIMESTER SCREENING  Between15 and 21 weeks of gestation Detailed ultrasound scan Maternal serum beta hCG Maternal serum AFP Maternal serum uE3 level Maternal serum inhibin A level
  • 10.  Beta hCG- peaks at 15 wks→ gradually falls at17-22wks Trisomy 21- increased in both trimesters  Alpha fetoprotein- produced by liver and gastrointestinal tract of fetus - marker of open spina bifida - Trisomy 21 ↓ by 25%  Free Estriol- Trisomy 21 ↓ by 25%  Inhibin A- ↑ to 1.77 MoM in trisomy 21
  • 11. COMBINED FIRST AND SECOND TRIMESTER SCREENING  Integrated screening NT+ serum analytes at 11 to 14 weeks+ quadruple markers at 15 to 20 weeks Highest Down syndrome detection rate( 94-96%)  Sequential screening stepwise sequential screening contingent sequential screening
  • 12. CELL FREE FETAL DNA SCREENING  Non invasive prenatal screening  Not recommended for multiple gestation  High specificity and sensitivity for trisomy 18 and 21  Doesnot assess risk of fetal anomalies such as neural tube defects or ventral wall defects  Recommended for women >35 yrs usg findings of increased risk of aneuploidy H/O trisomy affected offspring positive first or second trimester screening result parent wth balanced robertsonian translocation ACOG 2015
  • 13. GENETIC COUNSELING  3% of newborns have major congenital anomalies.  Etiologic factors: 1. Chromosomal abnormalities 2. Single gene disorders 3. Polygenic or multifactorial disorders 4. Teratogenic disorders due to exposure of exogenous factors
  • 14. MATERNAL RISK FACTORS  Maternal age > 35 years  Family history of neural tube defects  Previous baby born with neural tube defect  Previous child with chromosomal anomaly  One or both parents – carriers of sex linked or autosomal traits  One parent is known to carry a balanced translocation  History of recurrent miscarriage
  • 15. PRENATAL RISK FACTORS  Oligohydramnios  Polyhydramnios  Severe symmetrical IUGR  Abnormal USG findings
  • 16.  Uncontrolled diabetes mellitus in the periconceptional period  Contact with infection  Presence of soft tissue markers  Abnormal maternal serum screening
  • 17. INVASIVE PROCEDURE FOR PRENATAL DIAGNOSIS  Chorionic villus sampling  Amniocentesis  Cordocentesis or percutaneous umbilical blood sampling
  • 18. CHORIONIC VILLUS SAMPLING  Diagnosed by italian biologist Giuseppe simoni, 1983  Diagnosis of genetic disorders 3 approaches:  Transcervically-10wks to 13 wks  Transabdominally-10wks to term  Transvaginal(rare)
  • 20. ADVANTAGES OF TRANSCERVICAL CVS  Genetic diagnosis is achieved at an early gestational age.  Comfortable to the patient  Technically simple.
  • 21. DISADVANTAGES  High risk of fetal loss than traditional amniocentesis  Chromosome composition & enzyme composition of the chorionic villus is ocassionally different from the fetal cells  Difficult if the placenta is above the lower one third of the uterus
  • 22. CONTRAINDICATIONS -Positive neisseria gonorrhoea culture of the cervix -Active genital herpes -Active bleeding -Maternal coagulopathy -Cervical stenosis -Severe cervicitis -Uterine myomas -IUD inside the pregnant uterus.
  • 23. TRANSABDOMINAL CVS  It certainally reduces the potential risk of infection when compared to vaginal procedure.  Two techniques -Single needle -Two needle
  • 25. ADVANTAGES OF TRANSABDOMINAL CVS  Minimal risk of infection  It does not cause vaginal bleeding  Performed in the second and third trimester.
  • 26. DISADVANTAGES  Amount of tissue obtained is less than that with transcervical cvs.  Patient discomfort is more.  Difficult to perform if placenta is posterior.
  • 28.  Chorionic villus is obtained by transvaginal aspiration under guidance with an endovaginal probe.
  • 29. LABORATORY ASPECTS OF CVS  Direct cytogenetic analysis  Long term tissue culture
  • 30. COMPLICATIONS  Fetal loss(1-2%)  Oromandibular limb deformities  Vaginal bleeding  Limb reduction deformity
  • 31. False positive results (2-3%) - placental mosaics and maternal cell contamination
  • 32. AMNIOCENTESIS DEF: Deliberate puncture of the amniotic fluid sac per abdomen
  • 33.  Carried out as an op procedure.  Early:11-14 , Late: 14-16  Proper counselling.  USG examination.
  • 34.
  • 35.  Main risk factors: -Rh isoimmunization in Rh negative mothers. -Infection
  • 36.  Other risks: -Changes with the gestational age -Preprocedure or concominant use of the USG. -Size of the needle -Number of needle insertions -Characteristics of the amniotic fluid -Experience & ability of the indivudual performance.
  • 37. ADVANTAGES  Degree of accuracy  Degree of hemolytic process in the fetus
  • 38.  Disadvantages: -Pregnancy loss -Amniotic fluid leekage -Fetal trauma
  • 39. PRECAUTIONS  Prior sonographic localisation of placenta is desirable to prevent bloody tap and fetomaternal bleeding  Prophylatic administration of 100mg of anti-D immunoglobulin in Rh-negative nonimmunized mother.
  • 40. CORDOCENTESIS  Described in 1983 by Fernand Daffos.  Procedure to obtain fetal blood. INDICATIONS: -Fetal transmission of toxoplasmosis -Rapid karyotype of the fetus with anatomic deformities -Chromosomal abnormalities
  • 42. USES:  Fetal abnormalities detected by USG.  Fetal growth retardation  Polyhydramnios  Hereditary defeciences of other haemostatic system  Hemoglobinopathies  Metabolic disorders.
  • 43. ADVANTAGES  High quality karyotype in 48-72 hrs rather than 10- 14 days that is needed for amniotic tissue culture.  Vein is larger in size.
  • 44. COMPLICATIONS  Bleeding from the puncture site(30%)  Fetal bradycardia(5%)
  • 45. CVS AMNIOCENETESI S CORDOCENTESIS TIME Transcervical 10- 13wks, Transadominal 10 weeks to term After 15 weeks(early 12-14 weeks) 18-20 weeks MATERIALS FOR STUDY Trophoblast cells Fetal fibroblasts Fluid for biochemical study Fetal white blood cells(others-infection and biochemical study) KARYOTYPE RESULT Direct preparation: 24-48 hrs Culture: 10-14 days Culture:3-4weeks 24-48hrs FETAL LOSS 0.5-1% 0.5% 1-2% ACCURACY Accurate Highly accurate Highly accurate TERMINATION OF PREGNANCY 1st trimester-safe 2nd trimester-risky 2nd trimester-risky
  • 46. HISTORY  Introduced initially in 1990, at Hammersmith Hospital, London  By Handyside .  Combines advances in molecular genetics & ART
  • 47. PGD INDICATIONS Procedure is offered to couples:  With known genetic disorders - autosomal recessive - autosomal dominant - x linked disorders - triplet repeat disorders  requesting sex selection for X- linked disorders  Chromosomal abnormalities
  • 48. PGD INDICATIONS The procedure has also been offered to couples: undergoing IVF at risk for aneuploidy maternal age > 35 years Prior trisomic conception with recurrent pregnancy losses Prior failed IVF cycles (>3 prior embryo transfers with high quality, morphologically normal embryos) Requesting PGD for HLA-typing (to allow selection of embryos that are histocompatible with live siblings) Requesting sex selection for “family balancing” Cancer predisposition syndromes.
  • 49. PRECONCEPTIONAL PRENATAL DIAGNOSTIC TECHNIQUES ACT(PC PNDT)  Why this act ? . Prohibition of sex selection . Detection of genetic abnormalities/ metabolic disorders/ chromosomal abnormalities/ congenital malformations/ sex linked disorders . Prevention of sex determination leading to female feticide
  • 50.  Genetic counseling centre- a gynecologist or a pediatrician having 6 months experience/ 4wks experience in genetic counseling/ a medical geneticists  Genetic laboratory- a medical geneticist/ a lab technician having 1 yr experience in conducting prenatal diagnostic procedures  Genetic clinic/ ultrasound clinic gynecologist having experience of performing at least 20 procedures a sonologist/ imaging specialist/ registered medical practitioner/ medical geneticists
  • 51. GENETIC TESTS  Cytogenetic analysis  Fluorescence in situ hybridization  Southern blotting  Polymerase chain reaction  Linkage analysis  Chromosomal micro array analysis
  • 53. FLUOROSCENCE IN SITU HYBRIDISATION
  • 55. TYPES OF CHROMOSOMAL ABNORMALITIES  Numerical - trisomy - monosomy  Structural- deletions/duplications/ translocations Chromosomal abnormality Genetic syndrome Incidence per 10000 births Trisomy 21 Down 15 Trisomy 18 Edward 3 Trisomy 13 Patau 2 Monosomy X Turner 2(female) XXY Klinefelter 10(male)
  • 56.  Translocation- reciprocal robertsonian  inversions – pericentric paracentric
  • 57. .